News Releases Year None2022202120202019201820172016 May 26, 2022 Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients with Prostate Cancer at the 2022 ASCO Annual Meeting May 13, 2022 Leap Therapeutics Reports First Quarter 2022 Financial Results Mar 11, 2022 Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results Mar 02, 2022 Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference Jan 31, 2022 Leica Biosystems and Leap Therapeutics Partner on Companion Diagnostic to Advance Care for Cancer Patients Jan 24, 2022 Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference Jan 18, 2022 Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI Cancers Symposium Jan 05, 2022 Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference Jan 03, 2022 Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
